This activity is expired and is no longer available for CME credit.


But How Similar Is It? What You Need to Know and What to Tell Your Patients about Biosimilars

Author(s)/Faculty: Jonathan Kay, MD; Edward Li, PharmD, BCOP; Russell D. Cohen, MD, FACG, AGAF; Hope Rugo, MD
Release Date: 12/20/2017Expiration Date: 12/19/2019
Credit Type: CMENumber of Credits: 0
Content Type: VideoProvider:
As more biosimilars are approved for use in the United States, all members of the multidisciplinary care team will require education about the appropriate incorporation of biosimilars into treatment paradigms. Currently, many providers lack knowledge about how biosimilars differ from their reference product as well as the regulatory processes by which biosimilars are approved. Expert faculty will summarize the current regulations for the manufacture and interchangeability of a biosimilar with its reference product and discuss the potential impact of biosimilars on healthcare outcomes. Participants will gain an understanding of the benefits and limitations of biosimilars, how they may fit into existing treatment algorithms, as well as the potential clinical and financial barriers regarding the use of biosimilars. Participants will learn how to discuss biosimilars with patients and other members of the multidisciplinary team.